October 19, 2026
Kyle A. Diamantas, JD
Acting Commissioner
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993
Re: Considerations for the Regulation of Generative AI-Enabled Medical Devices: Discussion Paper and Request for Feedback (FDA-2026-N-7874)